Eduardo Almeida Cunha Costa MD, Presenter: Nothing to Disclose

Amol Shah BS, Abstract Co-Author: Nothing to Disclose

Masahiro Tanabe MD, Abstract Co-Author: Nothing to Disclose

Jay P. Heiken MD, Abstract Co-Author: Patent agreement, Covidien AG Patent agreement, Bayer AG

Kathryn Jane Fowler MD, Abstract Co-Author: Research support, Bracco Group

Thomas A. Hope MD, Abstract Co-Author: Speaker, Guerbet SA Research Grant, General Electric Company

Cynthia Sawhney Santillan MD, Abstract Co-Author: Consultant, Robarts Clinical Trials Research Group

Michael Simca Middleton MD, PhD, Abstract Co-Author: Consultant, Allergan, Inc Institutional research contract, Bayer AG Institutional research contract, sanofi-aventis Group Institutional research contract, Isis Pharmaceuticals, Inc Institutional research contract, Johnson & Johnson Institutional research contract, Synageva BioPharma Corporation Institutional research contract, Takeda Pharmaceutical Company Limited Stockholder, General Electric Company Stockholder, Pfizer Inc Institutional research contract, Pfizer Inc

Claude B. Sirlin MD, Abstract Co-Author: Research Grant, General Electric Company Speakers Bureau, Bayer AG Consultant, Bayer AG

LI-RADS v2014 has been expanded to include hepatobiliary contrast agents. The purpose of this exhibit is to review hepatobiliary contrast agents content in LI-RADS v2014. By viewing this exhibit viewers should be familiar with possible imaging appearances of hepatocellular carcinoma (HCC)  at hepatobiliary agent-enhanced MRI as well as with the appearance of other malignant, pre-malignant and benign entities in patients with cirrhosis or other risk factors for HCC.

- Brief introduction to LI-RADS v.2014 - Introduction to hepatobiliary agents. Recognition of optimal and suboptimal uptake in delayed phase in patients with compensated and decompensated cirrhosis, and in non-cirrhotic livers. - Illustrative cases of hepatobiliary agents-enhanced MRI using LI-RADS v.2014 - Summary  

http://abstract.rsna.org/uploads/2014/14003354/14003354_vcjm.pdf

Costa, E, Shah, A, Tanabe, M, Heiken, J, Fowler, K, Hope, T, Santillan, C, Middleton, M, Sirlin, C, LI-RADS v2014: Interpretation and Categorization of MRI Findings Using Hepatobiliary Agents.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003354.html